Literature DB >> 21518880

IFN-lambda determines the intestinal epithelial antiviral host defense.

Johanna Pott1, Tanel Mahlakõiv, Markus Mordstein, Claudia U Duerr, Thomas Michiels, Silvia Stockinger, Peter Staeheli, Mathias W Hornef.   

Abstract

Type I and type III IFNs bind to different cell-surface receptors but induce identical signal transduction pathways, leading to the expression of antiviral host effector molecules. Despite the fact that type III IFN (IFN-λ) has been shown to predominantly act on mucosal organs, in vivo infection studies have failed to attribute a specific, nonredundant function. Instead, a predominant role of type I IFN was observed, which was explained by the ubiquitous expression of the type I IFN receptor. Here we comparatively analyzed the role of functional IFN-λ and type I IFN receptor signaling in the innate immune response to intestinal rotavirus infection in vivo, and determined viral replication and antiviral gene expression on the cellular level. We observed that both suckling and adult mice lacking functional receptors for IFN-λ were impaired in the control of oral rotavirus infection, whereas animals lacking functional receptors for type I IFN were similar to wild-type mice. Using Mx1 protein accumulation as marker for IFN responsiveness of individual cells, we demonstrate that intestinal epithelial cells, which are the prime target cells of rotavirus, strongly responded to IFN-λ but only marginally to type I IFN in vivo. Systemic treatment of suckling mice with IFN-λ repressed rotavirus replication in the gut, whereas treatment with type I IFN was not effective. These results are unique in identifying a critical role of IFN-λ in the epithelial antiviral host defense.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518880      PMCID: PMC3093475          DOI: 10.1073/pnas.1100552108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Immunity to homologous rotavirus infection in adult mice.

Authors:  M A Franco; H B Greenberg
Journal:  Trends Microbiol       Date:  2000-02       Impact factor: 17.079

2.  STAT1-dependent innate immunity to a Norwalk-like virus.

Authors:  Stephanie M Karst; Christiane E Wobus; Margarita Lay; John Davidson; Herbert W Virgin
Journal:  Science       Date:  2003-03-07       Impact factor: 47.728

3.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

4.  Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice.

Authors:  Andreas Pichlmair; Johanna Buse; Stephanie Jennings; Otto Haller; Georg Kochs; Peter Staeheli
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

Authors:  Sergei V Kotenko; Grant Gallagher; Vitaliy V Baurin; Anita Lewis-Antes; Meiling Shen; Nital K Shah; Jerome A Langer; Faruk Sheikh; Harold Dickensheets; Raymond P Donnelly
Journal:  Nat Immunol       Date:  2002-12-16       Impact factor: 25.606

6.  A recombinant human interferon-alpha B/D hybrid with a broad host-range.

Authors:  M A Horisberger; K de Staritzky
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

7.  The role of interferons in rotavirus infections and protection.

Authors:  John L Vancott; Monica M McNeal; Anthony H C Choi; Richard L Ward
Journal:  J Interferon Cytokine Res       Date:  2003-03       Impact factor: 2.607

8.  Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice.

Authors:  Jos A Boshuizen; Johan H J Reimerink; Anita M Korteland-van Male; Vanessa J J van Ham; Marion P G Koopmans; Hans A Büller; Jan Dekker; Alexandra W C Einerhand
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.

Authors:  Laure Dumoutier; Amel Tounsi; Thomas Michiels; Caroline Sommereyns; Sergei V Kotenko; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

10.  Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria.

Authors:  A Quaroni; J Wands; R L Trelstad; K J Isselbacher
Journal:  J Cell Biol       Date:  1979-02       Impact factor: 10.539

View more
  213 in total

1.  Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18.

Authors:  Benyue Zhang; Benoit Chassaing; Zhenda Shi; Robin Uchiyama; Zhan Zhang; Timothy L Denning; Sue E Crawford; Andrea J Pruijssers; Jason A Iskarpatyoti; Mary K Estes; Terence S Dermody; Wenjun Ouyang; Ifor R Williams; Matam Vijay-Kumar; Andrew T Gewirtz
Journal:  Science       Date:  2014-11-14       Impact factor: 47.728

Review 2.  The impact of perinatal immune development on mucosal homeostasis and chronic inflammation.

Authors:  Harald Renz; Per Brandtzaeg; Mathias Hornef
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

3.  Between vigilance and tolerance: the immune function of the intestinal epithelium.

Authors:  Cécilia Chassin; Mathias W Hornef
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

Review 4.  Establishment of intestinal homeostasis during the neonatal period.

Authors:  Silvia Stockinger; Mathias W Hornef; Cécilia Chassin
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

5.  Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.

Authors:  Eva Perez-Martin; Marcelo Weiss; Fayna Diaz-San Segundo; Juan M Pacheco; Jonathan Arzt; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

6.  Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain.

Authors:  Michelle M Arnold; Mario Barro; John T Patton
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

7.  Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier.

Authors:  Helen M Lazear; Brian P Daniels; Amelia K Pinto; Albert C Huang; Sarah C Vick; Sean E Doyle; Michael Gale; Robyn S Klein; Michael S Diamond
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

8.  MAVS-dependent host species range and pathogenicity of human hepatitis A virus.

Authors:  Asuka Hirai-Yuki; Lucinda Hensley; David R McGivern; Olga González-López; Anshuman Das; Hui Feng; Lu Sun; Justin E Wilson; Fengyu Hu; Zongdi Feng; William Lovell; Ichiro Misumi; Jenny P-Y Ting; Stephanie Montgomery; John Cullen; Jason K Whitmire; Stanley M Lemon
Journal:  Science       Date:  2016-09-15       Impact factor: 47.728

Review 9.  Type III Interferons in Antiviral Defenses at Barrier Surfaces.

Authors:  Alexandra I Wells; Carolyn B Coyne
Journal:  Trends Immunol       Date:  2018-09-12       Impact factor: 16.687

10.  Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.

Authors:  Isabella Rauch; Felix Rosebrock; Eva Hainzl; Susanne Heider; Andrea Majoros; Sebastian Wienerroither; Birgit Strobl; Silvia Stockinger; Lukas Kenner; Mathias Müller; Thomas Decker
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.